It can convert harmful stuff in the body into harmless substances and excrete them from the body
Managing these side effects may require small dietary adjustments such as small meal portions, avoiding greasy or fatty foods, and staying hydrated
Animal studies suggest high tolerance and no significant toxicity, even at large doses [44]
It increases the accessibility of such drugs, promotes compliance, and results in improved patient outcomes
The following sources give you the unfiltered picture - clinical evidence, regulatory context, and safety data straight from the organizations that publish it: FDA.gov - official FDA communications on compounded semaglutide, tirzepatide, and the 503B Bulks List proposal (April 30, 2026)
The benefits of expanded access to these drugs extend beyond mortality reduction, as it could also alleviate obesity-related comorbidities, including cardiovascular disease, diabetes, and even infections such as COVID-19